Time to recurrence after nephrectomy as a predictor of cancer-specific survival in localized clear-cell renal cell carcinoma

Urologia Internationalis

Volumn 86, Issue 1, 2011, Pages 47-52

  Rodriguez Covarrubias, Francisco ^a   Gomez Alvarado, M Olivia ^a   Sotomayor, Mariano ^a   Castillejos Molina, Ricardo ^a   Mendez Probst, Carlos E ^a   Gabilondo, Fernando ^a   Feria Bernal, Guillermo ^a  

^a INSTITUTO NACIONAL DE CIENCIAS MÉDICAS Y NUTRICIÓN SALVADOR ZUBIRÁN   (Mexico)

Author keywords

Nephrectomy; Prognosis; Recurrence; Renal cell carcinoma

Indexed keywords

ANTINEOPLASTIC AGENT; PROTEIN TYROSINE KINASE INHIBITOR; THALIDOMIDE;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER ADJUVANT THERAPY; CANCER COMBINATION CHEMOTHERAPY; CANCER GRADING; CANCER IMMUNOTHERAPY; CANCER INVASION; CANCER LOCALIZATION; CANCER MORTALITY; CANCER PATIENT; CANCER RECURRENCE; CANCER RELAPSE; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CANCER SURVIVOR; CAUSE SPECIFIC SURVIVAL; CLEAR CELL CARCINOMA; DISTANT METASTASIS; FEMALE; HUMAN; KIDNEY CARCINOMA; LUNG METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NEPHRECTOMY; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SARCOMATOID DIFFERENTIATION; TUMOR DIFFERENTIATION;

AGED; CARCINOMA, RENAL CELL; FEMALE; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEPHRECTOMY; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 79951810685     PISSN: 00421138     EISSN: None     Source Type: Journal    
DOI: 10.1159/000319368     Document Type: Article

References (21)

1. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ: Cancer statistics, 2007. CA Cancer J Clin 2007; 57: 43-66. (Pubitemid 46148091)
2. Aron M, Nguyen MM, Stein RJ, Gill IS: Impact of gender in renal cell carcinoma: an analysis of the SEER database. Eur Urol 2008; 54: 133-140.
3. Kovacs G, Akhtar M, Beckwith BJ, et al: The Heidelberg classification of renal cell tumors. J Pathol 1997; 183: 131-133.
4. Rodríguez-Covarrubias F, Gabilondo B, Borgen JL, Gabilondo F: Partial nephrectomy for renal tumors using selective parenchymal clamping. Int Urol Nephrol 2007; 39: 43-46. (Pubitemid 46722936)
5. Drucker BJ: Renal cell carcinoma: current status and future prospects. Cancer Treat Rev 2005; 31: 536-545. (Pubitemid 41614811)
6. Lam JS, Shvarts O, Leppert JT, Figlin RA, Belldegrun AS: Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy. J Urol 2005; 173: 1853-1862. (Pubitemid 40675199)
7. Stephenson AJ, Chetner MP, Rourke K, et al: Guidelines for the surveillance of localized renal cell carcinoma based on the patterns of relapse after nephrectomy. J Urol 2004; 172: 58-62. (Pubitemid 41615038)
8. Janzen NK, Kim HL, Figlin RA, Belldegrun AS: Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003; 30: 843-852. (Pubitemid 37485197)
9. Ficarra V: Re: Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. Eur Urol 2007; 51: 283.
10. Lane BR, Kattan MW: Prognostic models and algorithms in renal cell carcinoma. Urol Clin North Am 2008; 35: 613-625.
11. Magera JS, Leibovich BC, Lohse CM, et al: Association of abnormal preoperative laboratory values with survival after radical nephrectomy for clinically confined clear cell renal cell carcinoma. Urology 2008; 71: 278-282. (Pubitemid 351282342)
12. Freedland SJ, Humphreys EB, Mangold LA, Eisenberger M, Partin AW: Time to prostate specific antigen recurrence after radical prostatectomy and risk of prostate cancer specific mortality. J Urol 2006; 176: 1404-1408. (Pubitemid 44307204)
13. Eggener S, Yossepowitch O, Pettus J, Snyder ME, Motzer RJ, Russo P: Renal cell carcinoma recurrence after nephrectomy for localized disease: predicting survival from time of recurrence. J Clin Oncol 2006; 24: 3101-3106. (Pubitemid 46638947)
14. Knight DA, Stadler WM: Prognostic factors in localized renal cell cancer. BJU Int 2007; 99: 1212-1216. (Pubitemid 46624162)
15. Motzer RJ, Mazumdar M, Bacik J, Berg W, Amsterdam A, Ferrara J: Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999; 17: 2530-2540. (Pubitemid 29368255)
16. Cheville JC, Lohse CM, Zincke H, et al: Sarcomatoid renal cell carcinoma: an examination of underlying histologic subtype and an analysis of associations with patient outcome. Am J Surg Pathol 2004; 28: 435-441. (Pubitemid 38436516)
17. Margulis V, Tamboli P, Matin SF, Meisner M, Swanson DA, Wood CG: Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma. J Urol 2007; 178: 1878-1882. (Pubitemid 47538591)
18. Rodríguez-Covarrubias F, Castillejos-Molina R, Sotomayor M, et al: Impact of lymph node invasion and sarcomatoid differentiation on the survival of patients with locally advanced renal cell carcinoma. Urol Int 2010; 85: 23-29.
19. Sorbellini M, Kattan MW, Snyder ME, et al: A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol 2005; 173: 48-51. (Pubitemid 39627669)
20. Zisman A, Pantuck AJ, Wieder J, et al: Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol 2002; 20: 4559-4566. (Pubitemid 35402959)
21. Patard JJ, Kim HL, Lam JS, et al: Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol 2004; 22: 3316-3322. (Pubitemid 41103688)